Indosat Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Indosat Tbk. trades at Rp2,520 (market cap 79.66T, 78.03M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp238 (market cap 164.65B, 45.9K 24h volume). The key difference: Indosat Tbk. is far larger — about 483.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Indosat Tbk. is more actively traded (78.03M versus 45.9K). Which is the better fit depends on your goals.
| ISAT | OBAT | |
|---|---|---|
Market Cap | 79.66T | 164.65B |
Volume | 78.03M | 45.9K |
Lot | 780.34K | 459 |
Turnover | 199.9B | 11.08M |
Average Price | 2,561.74 | 241.33 |
Value | 199.9B | 11.08M |
Indicative Equilibrium Price | 2,500 | 238 |
Indicative Equilibrium Volume | 2.28K | 100 |
Trailing returns across standard periods
Latest headlines on both assets
Indonesian Satellite Corporation Tbk, PT (Persero), was established on November 10, 1967 within the framework of the Indonesian foreign Investment Law No. 1 of 1967. The company’s articles of association have been amended from time to time, most recently on Sept 4, 1997, concerning the changes in the articles of association to conform with Law No. 1 of 1995 on limited liability companies.
Read more on ISAT →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →